Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

418463

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps NHS England takes to assess the health and social care needs of patients with hidradenitis suppurativa; and what assessment he has made of the ability of the NHS to deliver efficient diagnosis and access to specialist care for such patients.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	10010
answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>NHS England works in partnership with local commissioners and providers to ensure people with long-term conditions, such as hidradenitis suppurativa (HS), are supported to live healthily and independently and are empowered to take better control over the care they receive.</p><p> </p><p> </p><p> </p><p>The majority of patients with HS can be managed through routine access to primary and secondary care, including dermatology clinics, which is responsibility of the local National Health Service commissioners. Treatment and management of the condition involves antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin, which a general practitioner may prescribe.</p><p> </p><p> </p><p> </p><p>For those patients with the more serious forms of HS, referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions, including HS, and has set out what providers must have in place in order to offer specialist dermatology care. This supports equity of access to a high quality service for patients wherever they live. These services may provide more intensive therapies with the involvement of a range of health and care professionals, subject to a patient’s needs. More information can be found by viewing the specialised dermatology service specification at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 10011 question first answered 16/09/2015 11:46:53 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

418464

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what progress has been made by NHS England on the production of a commissioning policy for treatments associated with hidradenitis suppurativa; what the proposed scope of that policy is; and when he expects that policy to have been fully developed.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	10011
answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>NHS England works in partnership with local commissioners and providers to ensure people with long-term conditions, such as hidradenitis suppurativa (HS), are supported to live healthily and independently and are empowered to take better control over the care they receive.</p><p> </p><p> </p><p> </p><p>The majority of patients with HS can be managed through routine access to primary and secondary care, including dermatology clinics, which is responsibility of the local National Health Service commissioners. Treatment and management of the condition involves antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin, which a general practitioner may prescribe.</p><p> </p><p> </p><p> </p><p>For those patients with the more serious forms of HS, referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions, including HS, and has set out what providers must have in place in order to offer specialist dermatology care. This supports equity of access to a high quality service for patients wherever they live. These services may provide more intensive therapies with the involvement of a range of health and care professionals, subject to a patient’s needs. More information can be found by viewing the specialised dermatology service specification at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 10010 question first answered 16/09/2015 11:46:53 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

418471

registered interest
date	11/09/2015
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Company Investigations: Freezing of Assets
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, whether Sussex Police are required to freeze the assets of a company they are investigating; on what grounds police may freeze the assets of a company they are investigating; and at what point such assets may be unfrozen if police bail has expired and no charges have been brought.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	9976
answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>The Proceeds of Crime Act 2002 permits an application for a restraint order to be made to “freeze” assets of an alleged offender, which includes a company, if there is reasonable cause to suspect that an offender has benefitted from their criminal conduct. A restraint order has the effect of freezing property that may be liable to confiscation following a trial and the subsequent making of a confiscation order. There is no legal requirement for a police force to freeze the assets of a company they are investigating, although it is good practice to do so in cases in which assets need to be preserved for confiscation at a later date. A restraint order may be made by a Crown Court if any of the following conditions are satisfied:</p><p>(1) A criminal investigation has been started in England and Wales and there is reasonable grounds to suspect that the alleged offender has benefitted from criminal conduct</p><p>(2) Proceedings for an offence have been commenced in England and Wales and not concluded and there is reasonable grounds to believe that an alleged offender has benefitted from criminal conduct.</p><p>In addition to the statutory conditions, there must be a real risk that the assets will be dissipated.</p><p>A restraint order can be varied or discharged upon application by a person affected by the order. The Proceeds of Crime Act also provides that the court is required to discharge any restraint order at the conclusion of proceedings. If an order is made under condition (1) above, the court is also required to monitor progress with the investigation, and if a decision to charge is not made within a reasonable time, the court may discharge the restraint order.</p> answering member constituency Hemel Hempstead answering member printed Mike Penning question first answered 16/09/2015 12:20:37 answering member 1528 label Biography information for Sir Mike Penning
tabling member	1538 label Biography information for Rosie Cooper